JAMA Network Home
Sign In
Viewpoint

GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain

JAMA Psychiatry 10.1001/jamapsychiatry.2025.2536

September 24, 2025 at 11:00 AM EDT

Read the full article

This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain.

Corresponding Author: Marco Zierhut, MD, Department of Psychiatry and Neuroscience, Campus Benjamin Franklin, Charité–Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany (marco.zierhut@charite.de).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.2536?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092425

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks